Fat intake and CNS functioning: Ageing and disease

Annals of Nutrition and Metabolism

Volumn 55, Issue 1-3, 2009, Pages 202-228

  Crawford, Michael A ^a   Bazinet, Richard P ^b   Sinclair, Andrew J ^c  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID;

AGGRESSION; AGING; ALZHEIMER DISEASE; ANTISOCIAL BEHAVIOR; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN GROWTH; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; COGNITION; DEPRESSION; DEVELOPING COUNTRY; DRUG MECHANISM; EVOLUTION; FAT INTAKE; HOSTILITY; HUMAN; HUNTINGTON CHOREA; MAJOR DEPRESSION; MENTAL HEALTH; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SCHIZOPHRENIA;

AGING; BRAIN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; FOOD SUPPLY; HUMANS; MALE; MENTAL DISORDERS; NUTRITION POLICY;

EID: 70349273001     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229003     Document Type: Review

References (204)

1. Abeywardena MY, Head RJ: Long chain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res 2001; 52: 361-371.
2. Akbar M, Calderon F, Wen Z, Kim HY: Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005; 102: 10858-10863.
3. Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J: Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12(suppl 1):1-27.
4. Appleton KM, Rogers PJ, Ness AR: Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. Nutr Res Rev 2008; 21: 13-41.
5. AgREDS Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol 2001; 119: 1417-1436.
6. AREDS: Age-related Eye Disease Study 2 Manual of Procedures. 2006. www.areds2.org (accessed February 21, 2008).
7. Arnarsson A, Sverrisson T, Stefansson E, Sigurdsson H, Sasaki H, Sasaki K, Jonasson F: Risk factors for five-year incident age-related macular degeneration: The Reykjavik Eye Study. Am J Ophthalmol 2006; 142: 419-428.
8. Augood C, Chakravarthy U, Young I, et al: Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr 2008; 88: 398-406.
9. Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Dartigues JF, Renaud S: Fish, meat, and risk of dementia: Cohort study. BMJ 2002; 325: 932-933.
10. Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI: Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem 2007; 102: 761-772.
11. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ: Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: Relevance to bipolar disorder. Biol Psychiatry 2006; 59: 401-407.
12. Beltz BS, Tlusty MF, Benton JL, Sandeman DC: Omega-3 fatty acids upregulate adult neurogenesis. Neurosci Lett 2007; 415: 154-158.
13. Benolken RM, Anderson RE, Maude MB: Lipid composition of Limulus photoreceptor membranes. Biochimica et biophysica acta 1975; 413: 234-242.
14. Benolken RM, Anderson RE, Wheeler TG: Membrane fatty acids associated with the electrical response in visual excitation. Science 1973; 182: 1253-1254.
15. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR: Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007; 85: 1103-1111.
16. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG: A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000; 42: 174-181.
17. Bitsanis D, Ghebremeskel K, Moodley T, Crawford MA, Djahanbakhch O: Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 2006; 41: 341-346.
18. Bloom M, Linseisen F, Lloyd-Smith J, Crawford MA: Insights from NMR on the Functional Role of Polyunsaturated Lipids in the Brain; in Maraviglia B (ed): 'Magnetic Resonance and Brain Function: Approaches from Physics' Proc 1998 Enrico Fermi Int School Physics, Enrico Fermi Lecture, Varenna,1999, pp 1-27.
19. Bosetti F, Weerasinghe GR, Rosenberger TA, Rapoport SI: Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem 2003; 85: 690-696.
20. Boston PF, Bennett A, Horrobin DF, Bennett CN: Ethyl-EPA in Alzheimer's disease: A pilot study. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 341-346.
21. Boudrault C, Bazinet RP, Ma DW: Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 2009; 20: 1-10.
22. Broadhurst CL, Wang Y, Crawford MA, Cunnane SC, Parkington JE, Schmidt WF: Brainspecific lipids from marine, lacustrine, or terrestrial food resources: Potential impact on early African Homo sapiens. Comp Biochem Physiol B Biochem Mol Biol 2002; 131: 653-673.
23. Budowski P, Crawford MA:-Linolenic acid as a regulator of the metabolism of arachidonic acid: Dietary implications of the ratio, n-6: n-3 fatty acids. Proc Nutr Soc 1985; 44: 221-229.
24. Budowski P, Leighfield MJ, Crawford MA: Nutritional encephalomalacia in the chick: An exposure of the vulnerable period for cerebellar development and the possible need for both n-6 and n-3 fatty acids. Br J Nutr 1987; 58: 511-520.
25. Buydens-Branchey L, Branchey M: n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 2006; 26: 661-665.
26. Calon F, Lim GP, Yang F, et al: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004; 43: 633-645.
27. Carlson SE, Werkman SH: A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996; 31: 85-90.
28. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem Jr N.: Cognitive deficits in docosahexaenoic acid-deficient rats. Behavioral neuroscience 2002; 116: 1022-1031.
29. Chalon S, Delion-Vancassel S, Belzung C, Guilloteau D, Leguisquet AM, Besnard JC, Durand G: Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 1998; 128: 2512-2519.
30. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265.
31. Chen S, Gjerde AU, Holmsen H, Nerdal W: Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: A 13 C and 31 P solid-state NMR study. Biophys Chem 2005; 117: 101-109.
32. Chisaki K, Okuda Y, Suzuki S, Miyauchi T, Soma M, Ohkoshi N, Sone H, Yamada N, Nakajima T: Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells. Hypertens Res 2003: 26: 655-661.
33. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE: Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001; 73: 209-218.
34. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH: Dietary omega-3 fatty acid and fish intake in the primary prevention of agerelated macular degeneration: A systematic review and meta-analysis. Arch Ophthalmol 2008; 126: 826-833.
35. Chua B, Flood V, Rochtchina E, Wang JJ, Smith W, Mitchell P: Dietary fatty acids and the 5- year incidence of age-related maculopathy. Arch Ophthalmol 2006; 124: 981-986.
36. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; AgREDS Group: Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS), AREDS report No. 19. Ophthalmology 2005; 112: 533-539.
37. Cole GM, Frautschy SA: Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health 2006; 18: 249-259.
38. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH: Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305-1312.
39. Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA: Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res 2006; 146: 179-184.
40. Crawford M: Placental delivery of arachidonic and docosahexaenoic acids: Implications for the lipid nutrition of preterm infants. Am J Clin Nutr 2000; 71(1 suppl):275S-284S.
41. Crawford MA: Lipids and development of the human brain. Biochem Soc trans 1976; 4: 231-233.
42. Crawford MA, Casperd NM, Sinclair AJ: The long chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol B 1976a;54:395-401.
43. Crawford MA, Crawford SM: What We Eat Today. London, Spearman, 1972, p 142.
44. Crawford MA, Cunnane SC, Harbige LS: A new theory of evolution: Quantum theory; in Sinclair AJ, Gibson NA (eds): 3rd International Congress on Essential Fatty Acids and Eicosanoids. American Oil Chemists' Society, Adelaide, 1993, pp 87-95.
45. Crawford MA, Golfetto I, Bistanis D, Ghebremeskel K, Min Y, Moodley T, Poston L, Phylactos A, Cunnane S, Schmidt W: Arachidonic and docosahexaenoic acids in protection against central nervous system damage in preterm infants. Lipids 2003; 38: 303-315.
46. Crawford MA, Hassam AG, Williams G: Essential fatty acids and foetal brain growth. Lancet 1976b;1: 452-453.
47. Crawford MA, Leigh Broadhurst C, Galli C, Ghebremeskel K, Holmsen H, Saugstad LF, Schmidt F, Sinclair AJ, Cunnane SC: The role of docosahexaenoic and arachidonic acids as determinants of evolution and hominid brain development; in Tsukamoto K, Kawamura T, Takeuchi T, Beard T.D. Jr, Kaiser MJ (eds): Fisheries for Global Welfare and Environment. 5th World Fisheries Cong 2008, pp 57-76.
48. Crawford MA, Sinclair AJ: Nutritional influences in the evolution of mammalian brain; in Lipids, Malnutrition and the Developing Brain. Ciba Found Symp, 1972, pp 267-292.
49. Cukierman-Yaffee T: The relationship between dysglycemia and cognitive dysfunction. Curr Opin Investig Drugs 2009; 10: 70-74.
50. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P: The omega-3 fatty acid docosahexaenoate reduces cytokine- induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-1836.
51. Delcourt C, Carriere I, Cristol JP, Lacroux A, Gerber M: Dietary fat and the risk of age-related maculopathy: The POLANUT study. Eur J Clin Nutr 2007; 61: 1341-1344.
52. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH: Associations of cardiovascular disease and its risk factors with age-related macular degeneration: The POLA study. Ophthalmic Epidemiol 2001; 8: 237-249.
53. DeMar JC Jr, et al: One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 2006; 47: 172-180.
54. de Sá Roriz-Filho J, De-Sá-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves ML, Moriguti JC, Roriz-Cruz M: (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2008; 1792: 432-443.
55. Doyle W, Crawford MA, Wynn AHA, Wynn SW: Maternal nutrient intake and birth weight. J Hum Nutr Diet 1989; 2: 407-414.
56. Ellis EF, Police RJ, Dodson LY, McKinney JS, Holt SA: Effect of dietary n-3 fatty acids on cerebral microcirculation. Am J Physiol 1992; 262:H1379-H1386.
57. Enard W, Khaitovich P, Klose J, et al: Intra- and interspecific variation in primate gene expression patterns. Science 2002; 296: 340-343.
58. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, Breteler MM: Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 2002; 59: 1915-1921.
59. Espinosa-Heidmann DG, Sall J, Hernandez EP, Cousins SW: Basal laminar deposit formation in APO B100 transgenic mice: Complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 2004; 45: 260-266.
60. Fiennes RN, Sinclair AJ, Crawford MA: Essential fatty acid studies in primates linolenic acid requirements of capuchins. J Med Primatol 1973; 2: 155-169.
61. Fliesler SJ, Anderson RE: Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983; 22: 79-131.
62. Florent S, Malaplate-Armand C, Youssef I, et al: Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 2006; 96: 385-395.
63. Fontani G, Corradeschi F, Felici A, Alfatti F, Bugarini R, Fiaschi AI, Cerretani D, Montorfano G, Rizzo AM, Berra B: Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with omega- 3 polyunsaturated fatty acids. Eur J Clin Invest 2005; 35: 499-507.
64. Frangou S, Lewis M, McCrone P: Efficacy of ethyleicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. Br J Psychiatry 2006; 188: 46-50.
65. Frangou S, Lewis M, Wollard J, Simmons A: Preliminary in vivo evidence of increased N- acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol 2007; 21: 435-439.
66. Frasure-Smith N, Lesperance F, Julien P: Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004; 55: 891-896.
67. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ: Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113: 31-35.
68. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized doubleblind trial. Archives of Neurology 2006; 63: 1402-1408.
69. Friedman DA, Lukiw WJ, Hill JM: Apolipoprotein E epsilon4 offers protection against agerelated macular degeneration. Med Hypotheses 2007; 68: 1047-1055.
70. Galli C, Socini A: Dietary lipids in pre- and postnatal development; in Perkins EG, Visek WJ (eds): Dietary Fats and Health; American Oil Chemists' Society, Chicago, 1983, pp 278-301.
71. Gardier A: Mechanism of action of antidepressant drugs: Importance of genetically modified mice in the pharmacological in vivo approach (article in French). Therapie 2005; 60: 469-476.
72. Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ: Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners: Randomised, placebo-controlled trial. Br J Psychiatry 2002; 181: 22-28.
73. Gomez-Pinilla F: Brain foods: The effects of nutrients on brain function. Nat Rev 2008; 9: 568-578.
74. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L, LaFerla FM: Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007; 27: 4385-4395.
75. Greiner RS, Moriquchi T, Slotnick BM, Hutton A, Salem N: Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol Behav 2001; 72: 379-385.
76. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, Howe PR: Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1393-1396.
77. Deane EM, Caputi P, Howe PR: Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo- controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1393-1396.
78. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J: Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004; 161: 567-569.
79. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M: The effect of docosahexaenoic acid on aggression in young adults: A placebo-controlled double-blind study. J Clin Invest 1996; 97: 1129-1133.
80. Hamazaki T, Thienprasert A, Kheovichai K, Samuhaseneetoo S, Nagasawa T, Watanabe S: The effect of docosahexaenoic acid on aggression in elderly Thai subjects: A placebocontrolled double-blind study. Nutr Neurosci 2002; 5: 37-41.
81. Haubner LY, Stockard JE, Saste MD, et al: Maternal dietary docosahexanoic acid content affects the rat pup auditory system. Brain Res Bull 2002; 58: 1-5.
82. Heuberger RA, Mares Perlman JA, Klein R, Klein BE, Millen AE, Palta M: Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 2001; 119: 1833-1838.
83. Hibbeln JR: Fish consumption and major depression. Lancet 1998; 351: 1213.
84. Hibbeln JR: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord 2002; 69: 15-29.
85. Hibbeln JR, Ferguson TA, Blasbalg TL: Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention. Int Rev Psychiatry 2006a; 18: 107-118.
86. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 2006b; 83(suppl):1483S-1493S.
87. Hibbeln JR, Nieminen LR, Lands WE: Increasing homicide rates and linoleic acid consumption among five Western countries, 1961-2000. Lipids 2004; 39: 1207-1213.
88. Hindenes JO, Nerdal W, Guo W, Di L, Small DM, Holmsen H: Physical properties of the transmembrane signal molecule, sn-1-stearoyl 2- arachidonoylglycerol. Acyl chain segregation and its biochemical implications. J Biol Chem 2000; 275: 6857-6867.
89. Horrocks LA, Yeo YK: Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 1999; 40: 211-225.
90. Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC: Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005; 65: 1409-1414.
91. Iribarren C, Markovitz JH, Jacobs DR Jr, Schreiner PJ, Daviglus M, Hibbeln JR: Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults: The CARDIA study. Eur J Clin Nutr 2004; 58: 24-31.
92. Itomura M, Hamazaki K, Sawazaki S, Kobayashi M, Terasawa K, Watanabe S, Hamazaki T: The effect of fish oil on physical aggression in schoolchildren: A randomized, doubleblind, placebo-controlled trial. J Nutr Biochem 2005; 16: 163-171.
93. Jacka FN, Pasco JA, Henry MJ, Kotowicz MA, Nicholson GC, Berk M: Dietary omega-3 fatty acids and depression in a community sample. Nutr Neurosci 2004; 7: 101-106.
94. Jager RD, Mieler WF, Miller JW: Age-related macular degeneration. N Engl J Med 2008; 358: 2606-2617.
95. James MJ, Cleland LG: Applying a research ethics committee approach to a medical practice controversy: The case of the selective COX-2 inhibitor rofecoxib. J Med Ethics 2004; 30: 182-184.
96. Jump DB: The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002; 277: 8755-8758.
97. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D: Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145: 33-41.
98. Katsumata T, Katayama Y, Obo R, Muramatsu H, Ohtori T, Terashi A: Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol 1999; 372: 167-174.
99. Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, et al: Double-blind, randomized, placebo-controlled trials of ethyl- eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 2006; 60: 1020-1022.
100. Kelley DS, Taylor PC, Nelson GJ, Schmidt PC, Ferretti A, Erickson KL, Yu R, Chandra RK, Mackey BE: Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999; 34: 317-324.
101. Kitajka K, et al: Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci USA 2004; 101: 10931-10936.
102. Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S: Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 2004; 89: 695-702.
103. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T: Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 2006; 56: 159-164.
104. Lagarde M, Bernoud N, Brossard N, Lemaitre-Delaunay D, Thiès F, Croset M, Lecerf J: Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J Mol Neurosci 2001; 16: 201-204; discussion 215-221. (Pubitemid 32664780)
105. Lands WEM: A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res 2008; 77-106.
106. Lauritzen L, Hansen HS, Jùrgensen MH, Michaelsen KF: The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001; 40: 1-94.
107. Leaf AA, Leighfield MJ, Costeloe KL, Crawford MA: Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J Pediatr Gastroenterol Nutr 1992; 14: 300-308.
108. Leone S, Ottani A, Bertolini A: Dual acting antiinflammatory drugs. Curr Top Med Chem 2007; 7: 265-275.
109. Leyton J, Drury PJ, Crawford MA: Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat. Br J Nutr 1987; 57: 383-393.
110. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole GM: A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005; 25: 3032-3040.
111. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P: Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. Am J Psychiatry 2002; 159: 1830-1840.
112. Lukiw WJ, Bazan NG: Docosahexaenoic acid and the aging brain. J Nutr 2008; 138: 2510-2514.
113. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005; 115: 2774-2783.
114. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin- 6, soluble interleukin-6, soluble interleukin- 2 and transferrin receptor in major depression. J Affect Disord 1995; 34: 301-309.
115. Malek G, Johnson LV, Mace BE, Saloupis P, Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Rickman CB: Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration. Proc Natl Acad Sci USA 2005; 102: 11900-11905.
116. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE: DNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 2000; 20: 771-782.
117. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ: A double-blind, placebo- controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160: 996-998.
118. Marcheselli VL, Hong S, Lukiw WJ, et al: Novel docosanoids inhibit brain ischemia-reperfusion- mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003; 278: 43807-43817.
119. Mares-Perlman JA, Brady WE, Klein R, Vanden-Langenberg GM, Klein BE, Palta M: Dietary fat and age-related maculopathy. Arch Ophthalmol 1995; 113: 743-748.
120. Martinez M, Vazquez E: MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 1998; 51: 26-32.
121. McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM: Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007; 62: 17-24.
122. Mohrhauer H, Holman RT: Effect of linolenic acid upon the metabolism of linoleic acid. J Nutr 1963; 81: 67-74.
123. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940-946.
124. Murck H, Manku M: Ethyl-EPA in Huntington disease: Potentially relevant mechanism of action. Brain Res Bull 2007; 72: 159-164.
125. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159: 477-479.
126. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH: Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. Am J Psychiatry 2006; 163: 1098-1100.
127. Neu P, Schlattmann P, Schilling A, Hartmann A: Cerebrovascular reactivity in major depression: A pilot study. Psychosom Med 2004; 66: 6-8.
128. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S: Biochemical and functional effects of prenatal and postnatal n-3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986; 83: 4021-4025.
129. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-7547.
130. Noaghiul S, Hibbeln JR: Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003; 160: 2222-2227.
131. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lutjohann D, Hartmann T, Tanila H: Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 2006; 23: 563-572.
132. Orr SK, Bazinet RP: The emerging role of docosahexaenoic acid in neuroinflammation. Curr Opin Investig Drugs 2008; 9: 735-743.
133. Oruch R, Hodneland E, Pryme I, Holmsen H: Effects of psychotropic drugs on polyphosphoinositide metabolism in human platelets: A result of receptor-independent drug intercalation in the plasma membrane? Biochim Biophys Acta, 2008; 1778: 2165-2176.
134. Osher Y, Bersudsky Y, Belmaker RH: Omega-3 eicosapentaenoic acid in bipolar depression: Report of a small open-label study. J Clin Psychiatry 2005; 66: 726-729.
135. Otsuka M, Yamaguchi K, Ueki A: Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition. Ann NY Acad Sci 2002; 977: 155-161.
136. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D: Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006; 163: 969-978.
137. Peet M: Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia. Israel J Psychiatry Relat Sci 2008; 45: 19-25.
138. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59: 913-919.
139. Pennisi E: Primate evolution: Gene activity clocks brain's fast evolution. Science 2002; 296: 233-235.
140. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR: Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 1998; 23: 81-88. (Pubitemid 28145695)
141. Puri BK, Counsell SJ, Richardson AJ, Horrobin DF: Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry 2002; 59: 91-92.
142. Puri BK, Leavitt BR, Hayden MR, et al: Ethyl-EPA in Huntington disease: A double-blind, randomized, placebo-controlled trial. Neurology 2005; 65: 286-292.
143. Raeder MB, Steen VM, Vollset SE, Bjelland I: Associations between cod liver oil use and symptoms of depression: The Hordaland Health Study. J Affect Disord 2007; 101: 245-249.
144. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
145. Rao JS, Ertley RN, Demar JC Jr, Rapoport SI, Bazinet RP, Lee HJ: Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 2007a; 12: 151-157.
146. Rao JS, Ertley RN, Lee HJ, DeMar JC Jr, Arnold JT, Rapoport SI, Bazinet RP: n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPKdependent mechanism. Mol Psychiatry 2007b;12: 36-46.
147. Rapoport SI, Rao JS, Igarashi M: Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 251-261. (Pubitemid 350214520)
148. Ray WA, Stein CM, Daugherty JR, et al: COX-2 selective non-steroidal antiinflammatory drugs and risk of serious coronary heart disease. Lancet 2002; 360: 1071-1073.
149. Rees G, Doyle W, Srivastava A, Brooke ZM, Crawford MA, Costeloe KL: The nutrient intakes of mothers of low birth weight babies: A comparison of ethnic groups in East London, UK. Matern Child Nutr 2005; 1: 91-99.
150. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP: Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851.
151. Robman L, Vu H, Hodge A, Tikellis G, Dimitrov P, McCarty C, Guymer R: Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol 2007; 42: 720-726.
152. Ross BM, Seguin J, Sieswerda LE: Omega-3 fatty acids as treatments for mental illness: Which disorder and which fatty acid? Lipids Health Dis 2007; 6: 21.
153. Samieri C, Féart C, Letenneur L, Dartigues JF, Pérès K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P: Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008; 88: 714-721.
154. Sanchez-Villegas A, Henríquez P, Figueiras A, Ortuño F, Lahortiga F, Martínez-González MA: Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 2007; 46: 337-346.
155. SanGiovanni JP, Chew EY: The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005; 24: 87-138.
156. SanGiovanni JP, Chew EY, Agron E, Clemons TE, Ferris FL 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Klein R, et al: The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008; 126: 1274-1279.
157. SanGiovanni JP, Chew EY, Clemons TE, et al: The relationship of dietary lipid intake and age-related macular degeneration in a casecontrol study: AREDS Report No. 20. Arch Ophthalmol 2007; 125: 671-679.
158. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol 2006; 63: 1545-1550.
159. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ: Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 2001; 119: 1259-1265.
160. Schins A, Crijns HJ, Brummer RJ, Wichers M, Lousberg R, Celis S, Honig A: Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatr Scand 2007; 115: 35-40.
161. Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH: An update on the genetics of age-related macular degeneration. Mol Vis 2007; 13: 196-205.
162. Seddon JM, Cote J, Davis N, Rosner B: Progression of age-related macular degeneration: Association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003a;121: 785-792.
163. Seddon JM, Cote J, Rosner B: Progression of agerelated macular degeneration: Association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003b;121: 1728-1737.
164. Seddon JM, George S, Rosner B: Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: The US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006; 124: 995-1001.
165. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W: Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001; 119: 1191-1199. (Pubitemid 32730008)
166. Serhan CN, Yacoubian S, Yang R: Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008; 3: 279-312.
167. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, et al: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or
168. Silvers KM, Scott KM: Fish consumption and self-reported physical and mental health status. Public Health Nutr 2002; 5: 427-431.
169. Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA: Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 211-218.
170. Sinclair AJ: Incorporation of radioactive polyunsaturated fatty acids into liver and brain of developing rat. Lipids 1975; 10: 175-184.
171. Sinclair AJ, Begg D, Mathai M, Weisinger RS: n-3 fatty acids and the brain: Review of studies in depression. Asia Pac J Clin Nutr 2007; 16(suppl 1):391-397.
172. Sinclair AJ, Crawford MA: The incorporation of linolenic aid and docosahexaenoic acid into liver and brain lipids of developing rats. FEBS Lett 1972; 26: 127-129.
173. Soderberg M, Edlund C, Kristensson K, Dallner G: Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991; 26: 421-425.
174. Song C, Horrobin D: Omega-3 fatty acid ethyleicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. J Lipid Res 2004; 45: 1112-1121.
175. Sprecher H: Interconversions between 20- and 22- carbon n-3 and n-6 fatty acids via 4-desaturase independent pathways; in Sinclair AJ, Gibson NA (eds): 3rd International Congress on Essential Fatty Acids and Eicosanoids. American Oil Chemists Society, Adelaide, 1993, pp 18-22.
176. Sprecher H, Chen Q, Yin FQ: Regulation of the biosynthesis of 22: 5n-6 and 22: 6n-3:A complex intracellular process. Lipids 1999; 34(suppl):S153-S156.
177. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ: The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 2008; 9: 57-64.
178. Stice E, Spoor S, Bohon C, Small DM, Stice E, Spoor S, Bohon C, Small DM: Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008; 322: 449-452.
179. Stoll AL, Locke CA, Marangell LB, Severus WE: Omega-3 fatty acids and bipolar disorder: A review. Prostaglandins Leukot Essent Fatty Acids 1999a;60: 329-337.
180. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: n-3 fatty acids in bipolar disorder: A preliminary double-blind, placebocontrolled trial. Arch Gen Psychiatry 1999b;56: 407-412.
181. Su KP, Huang SY, Chiu CC, Shen WW: Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13: 267-271.
182. Suzuki H, Manabe S, Wada O, Crawford MA: Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int J Vit Nutr Res 1997; 67: 272-278.
183. Suzuki H, Morikawa Y, Takahashi H: Effect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Rev Nutr Diet 2001; 88: 68-71.
184. Suzuki S, Akechi T, Kobayashi M, Taniguchi K, Goto K, Sasaki S, Tsugane S, Nishiwaki Y, Miyaoka H, Uchitomi Y: Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer 2004; 90: 787-793.
185. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H: Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 2001; 58: 512-513.
186. Tassoni DE, Kaur G, Weisinger RS, Sinclair AJ: The role of eicosanoids in the brain. Asia Pac J Clin Nutr 2008; 17(suppl 1):220-228.
187. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P: Fish consumption and depression: The Northern Finland 1966 birth cohort study. J Affect Disord 2004; 82: 447-452.
188. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ: Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br J Nutr 2003; 89: 483-489.
189. Umhau JC, Dauphinais KM, Patel SH, Nahrwold DA, Hibbeln JR, Rawlings RR, George DT: The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 2006; 60: 352-357.
190. Underhaug Gjerde A, Holmsen H, Nerdal W: Chlorpromazine interaction with phosphatidylserines: A 13 C and 31 P solid state NMR study. Biochim Biophys Acta 2004; 1682: 28-37.
191. Vaddadi KS, Gilleard C, Fryer H: Abuse of carers by relatives with severe mental illness. Int J Soc Psychiatry 2002; 48: 149-155.
192. van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D: Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen Elderly Study. Am J Clin Nutr 2007; 85: 1142-1147.
193. Virkkunen ME, Horrobin DF, Jenkins DK, Manku MS: Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders. Biol Psychiatry 1987; 22: 1087-1096.
194. Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ: Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 1996; 93: 12559-12563.
195. Walser B, Giordano RM, Stebbins CL: Supplementation with omega-3 polyunsaturated fatty acids augments brachial artery dilation and blood flow during forearm contraction. Eur J Appl Physiol 2006; 97: 347-354.
196. Wan M, Li Y, Xue H, Li Q, Li J: Eicosapentaenoic acid inhibits TNF-alpha-induced Lnk expression in human umbilical vein endothelial cells: Involvement of the PI3K/Akt pathway. J Nutr Biochem 2007; 18: 17-22.
197. Weisinger HS, Vingrys AJ, Bui BV, Sinclair AJ: Effects of dietary n-3 fatty acid deficiency and repletion in the guinea pig retina. Invest Ophthalmol Vis Sci 1999; 40: 327-338.
198. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC: n-3 fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: An observational follow-up study in late adulthood. Am J Clin Nutr 2008; 87: 449-454.
199. Wynn SW, Wynn AHA, Doyle W, Crawford MA: The association of maternal social class with maternal diet and the dimensions of babies in a population of London Women. Nutr Health 1994; 9: 303-315.
200. Xiao YF, Sigg DC, Leaf A: The antiarrhythmic effect of n-3 polyunsaturated fatty acids: Modulation of cardiac ion channels as a potential mechanism. Membr Biol: 2005; 206: 141-154.
201. Yates JR, Sepp T, Matharu BK, et al: Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007; 357: 553-561.
202. Yavin E, Himovichi E, Eilam R: Delayed cell migration in the developing rat brain following maternal Omega 3 alpha linolenic acid dietary deficiency. Neuroscience 2009; May 14, E-pub ahead of print.
203. Zanarini MC, Frankenburg FR: Omega-3 Fatty acid treatment of women with borderline personality disorder: A double-blind, placebo- controlled pilot study. Am J Psychiatry 2003; 160: 167-169.
204. Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, Durand G, Chalon S: The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 2002; 75: 662-667.